To access this element change to forms mode OFF
Grant Award View - GA220225
New one-billion dose Viatris Australia manufacturing suite to secure...
GA ID:
GA220225
Agency:
Department of Industry, Science and Resources
Approval Date:
7-Dec-2021
Publish Date:
10-Mar-2022
Category:
Industry Innovation
Grant Term:
8-Mar-2022 to 17-Nov-2022
Value (AUD):
$1,100,000.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DISR 21/22 Growing innovative & competitive bus, industries & regions
Grant Program:
Supply Chain Resilience Initiative
Grant Activity:
New one-billion dose Viatris Australia manufacturing suite to secure supply of c
Purpose:
Through this project, Alphapharm Pty Ltd (trading as Viatris) will build a new manufacturing suite at its Carole Park, Queensland facility. The new manufacturing suite will house high-speed automated tablet and capsule manufacturing lines and produce up to an additional one billion doses of critical medicines a year. This project helps to safeguard access to critical products.
GO ID:
GO Title:
Manufacturing Strategy - Supply Chain Resilience Initiative (SCRI)
Internal Reference ID:
SCRI000090
Selection Process:
Open Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
ALPHAPHARM PTY LTD
Recipient ABN:
93 002 359 739
Grant Recipient Location
Suburb:
MILLERS POINT
Town/City:
MILLERS POINT
Postcode:
2000
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
QLD
Postcode:
4300
Country:
AUSTRALIA